4. Predictive risk modeling and personalised safety assessments One of the most promising applications of GenAI in pharmacovigilance is predictive risk modelling. By analysing longitudinal patient ...

The EMA may yet publish a list of performance indicators on the basis of a recommendation of the Pharmacovigilance Risk Assessment Committee, and we are currently assuming these will be the same ...

The result: in order to better assess these rare but serious cases and identify possible risk factors, CAR T-cell-specific assessment criteria should be defined in pharmacovigilance activities and ...

risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. The esteemed panel of ...

risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. The esteemed panel of ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for various blood cancers for which no other effective therapies are available.

Request To Download Free Sample of This Strategic Report @ Enhancing Pharmacovigilance Practices: The exponential growth of the pharmacovigilance and drug safety software market is driven by the ...

risk assessment, benefit-risk evaluation, regulatory updates, collaboration and the integration of artificial intelligence and digital technologies in pharmacovigilance. The esteemed panel of speakers ...